Ramipril: Difference between revisions
From Proteopedia
Jump to navigationJump to search
David Canner (talk | contribs) No edit summary |
David Canner (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
<applet load="" size="480" color="" frame="true" spin="on" Scene ="Ramipril/Rama/1" align="right" caption="Ramiprilat, the metabolite of Ramipril, also known as Altace"/> | <applet load="" size="480" color="" frame="true" spin="on" Scene ="Ramipril/Rama/1" align="right" caption="Ramiprilat, the metabolite of Ramipril, also known as Altace"/> | ||
===Better Known as: Altace=== | ===Better Known as: Altace or Ramipro=== | ||
* Marketed By: King Pharmaceuticals (Now part of Pfizer Inc.)<br /> | * Marketed By: King Pharmaceuticals (Now part of Pfizer Inc.)<br /> | ||
* Major Indication: Hypertension & Congestive Heart Failure<br /> | * Major Indication: Hypertension & Congestive Heart Failure<br /> | ||
